Medicamen Biotech Limited reported earnings results for the fourth quarter ended March 31, 2022. For the fourth quarter, the company reported sales was INR 227.54 million compared to INR 212.39 million a year ago. Revenue was INR 230.91 million compared to INR 217.76 million a year ago. Net income was INR 27.45 million compared to INR 36.47 million a year ago. Basic earnings per share from continuing operations was INR 2.25 compared to INR 2.99 a year ago. Diluted earnings per share from continuing operations was INR 2.25 compared to INR 2.99 a year ago.